✦ LIBER ✦

CK19 is superior to MUC1 as a marker of micrometastases in patients with non-small cell lung cancer (NSCLC)

✍ Scribed by Thomas A Aloia; David H Harpole Jr.; Thomas A D’Amico

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-389 The clinical value of lymphatic mi

✍ Verhagen, A.; Shirango, H.; Thunnissen, E.; Tjan-Heijnen, V.; van der Drift, M.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Serum MicroRNA as a Predictive Marker fo

✍ Bi, N.; Stanton, P.; Wang, W.; Kong, F. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A review of etoposide in patients with n

✍ Itri, L.M.; Gralla, R.J. 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 398 KB

Is bilobectomy superior to lobectomy in

✍ Huang, Biing-Shiun; Cheng, Ching-Yuan; Hsu, Wen-Hu; Wang, Liang-Shun; Huang, Min 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Is bilobectomy superior to lobectomy in

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 269 KB

Advance lung cancer inflammation index (

✍ Syed H Jafri, Runhua Shi, Glenn Mills 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 255 KB